Work

TP53 mutations in Pap test DNA are a potential biomarker of ovarian cancer risk in high-risk women (226)

Year: 2022

Type: conference-abstract

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01451-2

Authors: Talayeh Ghezelayagh, Jeanne Fredrickson, Jeffrey Krimmel-Morrison, Brendan Kohrn, Marc Radke, Enna Manhardt, Ronit Katz, Barbara Norquist, Elizabeth Swisher, Rosana Risques

Institutions: University of Washington, University of Washington Medical Center

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295227486

Cites:

Cited by:

Related to: 10